擴核生醫科技股份有限公司
Update：2026/03/31
Industries
Main Industry
Biotechnology
Main Product/Service
Touchstone DX Laboratory Automation Solution integrates incubators, microscopes, centrifuges, and other laboratory equipment into a single compact unit. The device is lightweight and approximately the size of a shoebox. Through the design of 3D fluid cartridges and a multi-dimensional control system, researchers can customize automated experimental workflows. The system automatically performs various experiments based on the researcher’s settings, such as adding reagents to control liquid flow or using the microscope to monitor cell activity changes. This solution aims to help small and medium-sized biomedical and pharmaceutical laboratories increase drug development efficiency while reducing costs.
Founded Year
2021
Unified Business No.
90832791
Status
Active
Number of Employees
6
Total Paid-in
Capital
1,836,794 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Coherence Biotech develops a benchtop, distributed automation platform for cell-based assays. Our compact system integrates AI and automation to accelerate drug discovery, making advanced workflows more efficient and accessible across labs of all sizes, closing the wet-lab bottleneck and tightening the feedback loop between computational models and real biology.
